"Losing sleep can wreak havoc on your mind and body, experts say. In fact, missing out on just one night's sleep can trigger physical symptoms, such as upper respiratory issues, aches and ...

Getting enough sleep? Chances are you're not. Fortunately, there's a new study out that shows the path to better sleep. It's right in front of us, consistent with previous research, and offers ...

A new study that analyzed work schedules ... and getting less sleep than other groups, such as white people or those with higher levels of education. Han’s research indicates that the impact ...

Zepbound, a drug that rivals Ozempic, may one day be a treatment for sleep apnea, according to results from a new study. Jessica is a writer on the Wellness team with a focus on health news.

Weight loss drugs like Ozempic and Mounjaro have gained great traction in recent months, and now drugmakers have found another benefit of the popular medications. Eli Lilly, the manufacturer of ...

A Zepbound injection pen. A study showed the Eli Lilly drug mitigated sleep apnea while helping patients lose weight. (Shelby Knowles/Bloomberg News) A new study is boosting stock in drugmaker Eli ...

Eli Lilly's weight loss-related drug Zepbound could potentially be used to reduce the severity of sleep apnea in adults with obesity, according to a recent study. Results of a phase three ...

Lilly evaluated its GLP-1 drug called tirzepatide, sold as Zepbound for obesity and Mounjaro for type 2 diabetes, in patients with obstructive sleep apnea and obesity. In the first study ...

Advertisement In the first study, sleep apnea patients did not use CPAP (continuous positive airway pressure) machines, which blow air into the airway to keep it from collapsing during sleep.

The diabetes and weight loss drug tirzepatide appears to help people with obesity who also have sleep apnea ... Lilly declined to provide the full study or additional data to USA TODAY.

The Browns are tweaking their look for the 2024 season. The team announced on Wednesday that their regular helmets will feature white facemasks this year. The team wore them for one game in each of ...

The risk is particularly high for postmenopausal women, she noted. One study found that chronic short sleep duration led to a 20% increase in insulin levels among that group, compared to 15% overall.